PracticeUpdate Conference Series - ANZAN 2018

DYSPHAGIA 1

MUSCLE PAIN 1

PROXIMAL MUSCLE WEAKNESS 1

RESPIRATORY INSUFFICIENCY 1

EXERCISE INTOLERANCE 3

FATIGUE 3

GAIT ABNORMALITIES 1

UNKNOWN CAUSE OF HYPERCKEMIA 2

FREQUENT FALLS 1

IT’S NOT IN YOUR PATIENT’S HEAD

SLEEP APNOEA 3

IT’S IN THEIR MUSCLES

If your patients have discussed experiencing any of these symptoms or test results with you, it’s time to consider Late-Onset Pompe Disease (LOPD). Pompe Disease affects approximately 1 in every 40,000 people, and is a progressive disease that gets worse over time. 1,4 Like many conditions, Pompe Disease can be managed and treated if it is diagnosed early. Test your patients for Late-Onset Pompe Disease using the Dried Blood Spot (DBS) Testing Kit, fully funded by Sanofi Genzyme.

Request your free DBS Testing Kit and Pompe Patient Booklet today by emailing: DBSkits@sanofi.com

For more information on Pompe Disease, please visit: https://sanofigenzymeonline.com.au/pompe-disease References: 1. Kishnani PS, et al. Gen Med 2006; 8: 267–88. 2. Lukacs Z, et al. Neurology 2016; 87: 295–8. 3. Chan J, et al. Mol Genet Metab 2017; 120:163–72. 4. American Association of Neuromuscular & Electrodiagnostic Medicine. Muscle Nerve 2009; 40: 149–60. sanofi-aventis Australia pty ltd trading as Sanofi Genzyme ABN 31 008 558 807.Talavera Corporate Centre,Building D, 12–24 Talavera Road,Macquarie Park,NSW 2113.GZANZ.MYOZ.16.08.0142a.Date of Preparation March 2018.AM7338.